论文部分内容阅读
Guillain-Barr啨综合征(GBS)和Miller Fisher综合征(MFS)的诊断标准随着临床研究的深入在不断演变。2011年1月,《疫苗》杂志发表了国际疫苗安全性监测Brighton合作组关于GBS/MFS的诊断定义和研究资料收集规范。此文献中未采用“诊断标准”而采用“诊断定义”是因为其主要目的为评价疫苗安全性而制定,而非用于神经科的GBS/
The diagnostic criteria of Guillain-Barr’s syndrome (GBS) and Miller Fisher’s syndrome (MFS) are evolving as clinical research progresses. In January 2011, Vaccine published the diagnostic definition and data collection specifications for the GBS / MFS for the Brighton Partnership for International Vaccine Safety Monitoring. This document does not use “diagnostic criteria” but “diagnostic definitions” because its primary purpose is to evaluate the safety of the vaccine rather than the neurological GBS /